These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 32735837)
1. Mortality risk associated with venous thromboembolism: a systematic review and Bayesian meta-analysis. Klemen ND; Feingold PL; Hashimoto B; Wang M; Kleyman S; Brackett A; Gross CP; Pei KY Lancet Haematol; 2020 Aug; 7(8):e583-e593. PubMed ID: 32735837 [TBL] [Abstract][Full Text] [Related]
2. Statins and primary prevention of venous thromboembolism: a systematic review and meta-analysis. Kunutsor SK; Seidu S; Khunti K Lancet Haematol; 2017 Feb; 4(2):e83-e93. PubMed ID: 28089655 [TBL] [Abstract][Full Text] [Related]
3. Heart failure and risk of venous thromboembolism: a systematic review and meta-analysis. Tang L; Wu YY; Lip GY; Yin P; Hu Y Lancet Haematol; 2016 Jan; 3(1):e30-44. PubMed ID: 26765646 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of oral anticoagulants for the extended treatment of venous thromboembolism using a mixed-treatment comparison, meta-analytic approach. Rollins BM; Silva MA; Donovan JL; Kanaan AO Clin Ther; 2014 Oct; 36(10):1454-64.e3. PubMed ID: 25092394 [TBL] [Abstract][Full Text] [Related]
5. The role of anticoagulation in venous thromboembolism primary prophylaxis in patients with malignancy: A systematic review and meta-analysis of randomized controlled trials. Barbarawi M; Zayed Y; Kheiri B; Gakhal I; Barbarawi O; Bala A; Alabdouh A; Abdalla A; Rizk F; Bachuwa G; Katato K Thromb Res; 2019 Sep; 181():36-45. PubMed ID: 31349093 [TBL] [Abstract][Full Text] [Related]
6. Editor's Choice - efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: a systematic review and meta-analysis of phase III trials. Kakkos SK; Kirkilesis GI; Tsolakis IA Eur J Vasc Endovasc Surg; 2014 Nov; 48(5):565-75. PubMed ID: 24951377 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis. Cohen AT; Hamilton M; Bird A; Mitchell SA; Li S; Horblyuk R; Batson S PLoS One; 2016; 11(8):e0160064. PubMed ID: 27487187 [TBL] [Abstract][Full Text] [Related]
8. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters. Schoot RA; Kremer LC; van de Wetering MD; van Ommen CH Cochrane Database Syst Rev; 2013 Sep; (9):CD009160. PubMed ID: 24026801 [TBL] [Abstract][Full Text] [Related]
9. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses. Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628 [TBL] [Abstract][Full Text] [Related]
10. Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm. Shantsila E; Lip GY Cochrane Database Syst Rev; 2016 Sep; 9(9):CD003333. PubMed ID: 27629776 [TBL] [Abstract][Full Text] [Related]
11. Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study. Brekelmans MP; Ageno W; Beenen LF; Brenner B; Buller HR; Chen CZ; Cohen AT; Grosso MA; Meyer G; Raskob G; Segers A; Vanassche T; Verhamme P; Wells PS; Zhang G; Weitz JI Lancet Haematol; 2016 Sep; 3(9):e437-45. PubMed ID: 27570090 [TBL] [Abstract][Full Text] [Related]
13. Editor's Choice - A Systematic Review and Meta-Analysis of the Efficacy and Safety of Anticoagulation in the Treatment of Venous Thromboembolism in Patients with Cancer. Kirkilesis GI; Kakkos SK; Tsolakis IA Eur J Vasc Endovasc Surg; 2019 May; 57(5):685-701. PubMed ID: 31097186 [TBL] [Abstract][Full Text] [Related]
14. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer. Akl EA; Vasireddi SR; Gunukula S; Barba M; Sperati F; Terrenato I; Muti P; Schünemann H Cochrane Database Syst Rev; 2011 Jun; (6):CD006649. PubMed ID: 21678360 [TBL] [Abstract][Full Text] [Related]
15. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer. Akl EA; Vasireddi SR; Gunukula S; Barba M; Sperati F; Terrenato I; Muti P; Schünemann H Cochrane Database Syst Rev; 2011 Apr; (4):CD006649. PubMed ID: 21491395 [TBL] [Abstract][Full Text] [Related]
16. Clinical and safety outcomes associated with treatment of acute venous thromboembolism: a systematic review and meta-analysis. Castellucci LA; Cameron C; Le Gal G; Rodger MA; Coyle D; Wells PS; Clifford T; Gandara E; Wells G; Carrier M JAMA; 2014 Sep; 312(11):1122-35. PubMed ID: 25226478 [TBL] [Abstract][Full Text] [Related]
17. Venous thromboembolism prevention in intracerebral hemorrhage: A systematic review and network meta-analysis. Yogendrakumar V; Lun R; Khan F; Salottolo K; Lacut K; Graham C; Dennis M; Hutton B; Wells PS; Fergusson D; Dowlatshahi D PLoS One; 2020; 15(6):e0234957. PubMed ID: 32579570 [TBL] [Abstract][Full Text] [Related]
18. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer. Akl EA; Kahale L; Neumann I; Barba M; Sperati F; Terrenato I; Muti P; Schünemann H Cochrane Database Syst Rev; 2014 Jun; (6):CD006649. PubMed ID: 24945634 [TBL] [Abstract][Full Text] [Related]
19. Low-Molecular-Weight Heparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Arthroscopic Surgery and Anterior Cruciate Ligament Reconstruction: A Meta-analysis of Randomized Controlled Trials. Zhu J; Jiang H; Marshall B; Li J; Tang X Am J Sports Med; 2019 Jul; 47(8):1994-2002. PubMed ID: 30113231 [TBL] [Abstract][Full Text] [Related]